| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |